<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Intern Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Korean J. Intern. Med</journal-id>
      <journal-id journal-id-type="publisher-id">KJIM</journal-id>
      <journal-title-group>
        <journal-title>The Korean Journal of Internal Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1226-3303</issn>
      <issn pub-type="epub">2005-6648</issn>
      <publisher>
        <publisher-name>The Korean Association of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22707896</article-id>
      <article-id pub-id-type="pmc">3372808</article-id>
      <article-id pub-id-type="doi">10.3904/kjim.2012.27.2.221</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Aldosterone-Producing Adrenocortical Carcinoma without Hypertension</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Min Soo</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Seo</surname>
            <given-names>Sung Woo</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bae</surname>
            <given-names>Sang Byung</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>Yeo Joo</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Sang Jin</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea.</aff>
      <author-notes>
        <corresp>Correspondence to Yeo Joo Kim, M.D. Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330-930, Korea. Tel: 82-41-570-3672, Fax: 82-41-574-5762, <email>yeojoo@schch.co.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>5</month>
        <year>2012</year>
      </pub-date>
      <volume>27</volume>
      <issue>2</issue>
      <fpage>221</fpage>
      <lpage>223</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>6</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>29</day>
          <month>8</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>8</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2012 The Korean Association of Internal Medicine</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Although adrenocortical tumors are common, adrenocortical carcinomas are rare. Moreover, aldosterone-producing adrenocortical carcinomas without hypertension are exceedingly rare, with only two previously reported cases.</p>
      </abstract>
      <kwd-group>
        <kwd>Aldosterone</kwd>
        <kwd>Carcinoma</kwd>
        <kwd>Hypertension</kwd>
        <kwd>Hyperaldosteronism</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Primary aldosteronism is a syndrome characterized by hypertension and hypokalemia [<xref ref-type="bibr" rid="B1">1</xref>]. Aldosterone-producing adenomas (APAs) and bilateral idiopathic hyperaldosteronism (IHA) are the most common causes of primary aldosteronism, with APA accounting for approximately 35% of the cases, and IHA accounting for 60% [<xref ref-type="bibr" rid="B2">2</xref>]. Aldosterone-producing adrenocortical carcinomas (APACs) are a very rare cause of primary aldosteronism [<xref ref-type="bibr" rid="B3">3</xref>]. As a cause of primary aldosteronism, an APAC is characterized by hypertension and hypokalemia [<xref ref-type="bibr" rid="B3">3</xref>]; however, very few APACs have features of normotensive primary aldosteronism [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Here, we report a case of APAC without hypertension.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 32-year-old woman was referred to our hospital for evaluation of a left adrenal mass. She had undergone an appendectomy 2 weeks earlier, and the mass was diagnosed incidentally on postoperative abdominal ultrasonography. On admission, her blood pressure was 110/70 mmHg, and her pulse was 80 beats/min. Serial blood pressures during her hospital stay ranged from 110/70 to 130/80 mmHg. The patient had hypokalemia (2.5 mmol/L) and was started on spironolactone (100 mg twice daily) and oral potassium chloride. The plasma aldosterone level was 389.53 pg/mL (normal range, 10.0 to 105) in the supine position and 716.87 pg/mL in the upright position (normal range, 34.0 to 273.0). Plasma rennin activity was 0.1 nmol/L/hr. Computed tomography showed a solid, homogenous adrenal mass with a maximum diameter of 42 mm (<xref ref-type="fig" rid="F1">Fig. 1</xref>). An adrenalectomy with lymphadenectomy was performed. The tumor was an ill-defined, gray-tan solid mass measuring 42 &#xD7; 33 &#xD7; 22 mm (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Histopathologically, it consisted of a solid nest of bland to anaplastic cells with frequent mitoses and necrosis (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Her potassium level normalized on postoperative day 7 without potassium supplements or spironolactone.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>In approximately 60% of cases, an adrenocortical carcinoma presents with evidence of adrenal steroid hormone excess [<xref ref-type="bibr" rid="B6">6</xref>], while APACs are exceedingly rare. To our knowledge, only 59 cases have been reported, including our case [<xref ref-type="bibr" rid="B3">3</xref>]. An apac is usually associated with hypokalemia, renal potassium leakage, and arterial hypertension due to excessive aldosterone secretion. A few specific symptoms such as muscle weakness and cramping, headache, palpitations, polydipsia, polyuria, and nocturia, or a combination of these symptoms, may be present in cases of marked hypokalemia [<xref ref-type="bibr" rid="B7">7</xref>]. Patients with suspected primary aldosteronism can be screened by measuring the morning ambulatory paired random plasma aldosterone concentration and plasma renin activity [<xref ref-type="bibr" rid="B2">2</xref>]. However, several studies have shown that most patients with primary aldosteronism have baseline blood potassium levels in the normal range [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. Consequently, hypokalemia is not used to establish the diagnosis of primary aldosteronism, and an increased ratio of plasma aldosterone concentration to plasma renin activity is not diagnostic in itself [<xref ref-type="bibr" rid="B2">2</xref>]. Primary aldosteronism can be confirmed by an oral sodium loading test, an intravenous saline infusion test, or a fludrocortisone suppression test [<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>An APAC is a rare cause of primary aldosteronism. Typically, a patient with an APAC has features of primary aldosteronism, including hypertension and hypokalemia. Nevertheless, two of the 58 reported APAC patients had normal blood pressure [<xref ref-type="bibr" rid="B3">3</xref>]. The two cases of APAC without hypertension were reported by Muthusethupathi et al. [<xref ref-type="bibr" rid="B4">4</xref>] and Yamazaki et al. [<xref ref-type="bibr" rid="B5">5</xref>] Information on these two published cases and our case is summarized in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
      <p>Vantyghem et al. [<xref ref-type="bibr" rid="B7">7</xref>] presented two cases of apa without hypertension; including these two cases, 18 cases of normotensive primary hyperaldosteronism have been reported. Only 10 of these cases have been published in the English literature, and about 75% of cases have been reported in Eurasians. Of the three cases listed in <xref ref-type="table" rid="T1">Table 1</xref>, one patient was Japanese, and another patient was Korean; no information was available regarding the third.</p>
      <p>The normal blood pressure in these rare cases of primary aldosteronism is not fully understood, and various explanations have been offered, including an absence of volume expansion, a low-salt diet, abnormal atrial natriuretic peptide activity, and the use of glucocorticoids [<xref ref-type="bibr" rid="B7">7</xref>]. The patients might have been hypotensive before the onset of the disease, might have experienced a blunted response to pressor agents, or might have exhibited associated hypopituitarism [<xref ref-type="bibr" rid="B4">4</xref>]. The exact cause of this disease in our patient remains unknown.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>No potential conflict of interest relevant to this article was reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ganguly</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Primary aldosteronism</article-title>
          <source>N Engl J Med</source>
          <year>1998</year>
          <volume>339</volume>
          <fpage>1828</fpage>
          <lpage>1834</lpage>
          <pub-id pub-id-type="pmid">9854120</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>WF</given-names>
            </name>
          </person-group>
          <article-title>Primary aldosteronism: renaissance of a syndrome</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>2007</year>
          <volume>66</volume>
          <fpage>607</fpage>
          <lpage>618</lpage>
          <pub-id pub-id-type="pmid">17492946</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seccia</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Fassina</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nussdorfer</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Pessina</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>GP</given-names>
            </name>
          </person-group>
          <article-title>Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course</article-title>
          <source>Endocr Relat Cancer</source>
          <year>2005</year>
          <volume>12</volume>
          <fpage>149</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="pmid">15788646</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muthusethupathi</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Vimala</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jayakumar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rajendran</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Normotensive primary aldosteronism due to adrenocortical carcinoma</article-title>
          <source>Nephron</source>
          <year>1998</year>
          <volume>79</volume>
          <fpage>247</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="pmid">9647521</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamazaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Katoh</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism in vivo</article-title>
          <source>APMIS</source>
          <year>1998</year>
          <volume>106</volume>
          <fpage>1056</fpage>
          <lpage>1060</lpage>
          <pub-id pub-id-type="pmid">9890267</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allolio</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fassnacht</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Clinical review: Adrenocortical carcinoma: clinical update</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2006</year>
          <volume>91</volume>
          <fpage>2027</fpage>
          <lpage>2037</lpage>
          <pub-id pub-id-type="pmid">16551738</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vantyghem</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Ronci</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Provost</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Aldosterone-producing adenoma without hypertension: a report of two cases</article-title>
          <source>Eur J Endocrinol</source>
          <year>1999</year>
          <volume>141</volume>
          <fpage>279</fpage>
          <lpage>285</lpage>
          <pub-id pub-id-type="pmid">10474126</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>ST</given-names>
            </name>
          </person-group>
          <article-title>Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity</article-title>
          <source>Clin Chem</source>
          <year>2005</year>
          <volume>51</volume>
          <fpage>386</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="pmid">15681560</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Raji</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia</article-title>
          <source>J Hum Hypertens</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>129</fpage>
          <lpage>136</lpage>
          <pub-id pub-id-type="pmid">16292348</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Abdominal computed tomography reveals a solid, homogenous 42 &#xD7; 33-mm adrenal mass (arrow).</p>
      </caption>
      <graphic xlink:href="kjim-27-221-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Histopathologically, the aldosterone-producing adrenocortical carcinoma shows solid nests of bland to anaplastic cells, with frequent mitoses and necrosis (H&amp;E, &#xD7; 400).</p>
      </caption>
      <graphic xlink:href="kjim-27-221-g002"/>
    </fig>
    <table-wrap id="T1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Clinical features of the three cases of aldosterone-producing adrenocortical carcinoma without hypertension</p>
      </caption>
      <graphic xlink:href="kjim-27-221-i001"/>
      <table-wrap-foot>
        <fn>
          <p>ND, not descriptive.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
